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Edited by Michael R. BubbAbstract It is known that small glutamine-rich TPR-containing
protein (SGT) is the member of TPR motif family. However, the
biological functions of SGT remain unclear. In this paper, we re-
port that SGT plays a role in apoptotic signaling. Ectopic
expression of SGT enhances DNA fragment and nucleus break-
age after the induction of apoptosis. Increasing mRNA level of
SGT is also observed in 7721 cells undergoing apoptosis, knock-
down the expression of endogenous SGT contributes to the de-
crease of apoptosis of 7721 cells. Deletion analysis reveals that
TPR domain is critical to pro-apoptotic function of SGT. Fur-
thermore, we demonstrated that the PARP cleavage and cyto-
chrome c release are enhanced when SGT is overexpressed in
7721 cells during apoptosis. Collectively, our results indicate that
SGT is a new pro-apoptotic factor.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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TPR1. Introduction
The small glutamine-rich TPR-containing protein (SGT),
which was also termed as UBP, was ﬁrst identiﬁed as a binding
partner of the non-structural protein of autonomous parvovi-
rus H-1 [1]. Human SGT consists of three known TPR motifs
which were thought to mediate in protein–protein interaction
[2]. TPR motifs, which are found in a variety of proteins, reg-
ulate the cell cycle, protein folding, transcription, protein
transport, ubiquitin-protesomes, hormone receptor signaling,
and several other pathways [3]. However, the signiﬁcance of
TPR domain for the biological roles of SGT is unknown,
and the speciﬁc biologic functions of SGT remain to be eluci-
dated.
Recently, some interacting partner of SGT, such as NS1, hu-
man immune-deﬁciency virus-encoded Vpu protein [4,5], the
growth hormone receptor [6] and myostatin [7], were charac-
terized one after another, but the biological signiﬁcance of
these interactions is not clear. However, more and more evi-
dences suggest that SGT may be a cochaperone. It was demon-
strated that SGT can bind both heat shock cognate protein
(Hsc70) and heat shock protein (Hsp70), and regulate their*Corresponding author. Fax: +86 21 64164489.
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for Alzheimer disease, SGT was found to be present in protein
complexes including b-amyloid peptide, several chaperones
and chaperone-like protein. Furthermore, when SGT was
knockdown by dsRNA, the toxic eﬀect of exogenous expres-
sion of b-amyloid peptide was signiﬁcantly reduced, implying
that SGT may be involved in b-amyloid peptide-dependent
pathogenicity in this model system [10]. On the other hand,
rat SGT promoted the chaperone activity of Hsc70 in a tripar-
tite complex containing the cysteine string protein (Csp) and
Hsc70, which is thought to participate in vesicle-mediated neu-
ronal signal transduction [11]. Most recently, a cellular func-
tion of SGT was elucidated. It was showed that SGT is
present throughout the cell cycle and accumulated in midzone
and the midbody. Depletion of SGT contributes to the increase
of the mitotic index [12].
The fact that SGT-like protein is present in almost all
eukaryotes such as yeast, worm, ﬂy, and mammals [2] and a
great diversity of cellular functions of all known TPR motifs
raise the possibility that SGT has an additional cellular func-
tion. In this report, we substantiate this idea and present evi-
dences to conﬁrm that SGT is involved in apoptosis.2. Materials and methods
2.1. Materials
The 7721 hepatocarcinoma cell line and COS-1 cell line was ob-
tained from the Institute of Cell Biology, Academic Sinica. RPMI
1640 medium and DMEM was from Sigma. LipofectAMINETM Re-
agent was purchased from Invitrogen. Leupeptin, aprotinin, and phen-
ylmethylsulfonyl ﬂuoride were purchased from Sigma. [a-32P]ATP,
Hybond polyvinylidene diﬂuoride membrane, goat anti-mouse horse-
radish, and goat anti-rabbit horseradish peroxidase secondary anti-
body were from Santa Cruz Biotechnology, the monoclonal Hsp60
antibody was from Stressgen Biotechnologies, the polyclonal cyto-
chrome c antibody was from Cell Signaling, the monoclonal PARP
antibody was from Calbiochem, the monoclonal GFP antibody was
from Roche, and the enhanced chemiluminescence assay kit were pur-
chased from Amersham Biosciences. Annexin-V-FITC recombinant
protein was purchased from Bender MedSystems. Cycloheximide
(CHX) was from Sigma, Staurosporine (STS) was from Cell Signaling.
Other reagents were commercially available in China.
2.2. Plasmid construction
Full-length cDNA of SGT was generated through PCR with 0.1 lg
of human fetal liver cDNA library [13] as the template and the primers
used were primer 1 (sense) (5 0-GATGAATTCATGGACAACAAGA-
AGCGCC-3 0) and primer 2 (antisense) (5 0-GATCTCGAGTCACTC-
CTGCTGGTCGTC-3 0), the PCR product was inserted in-frame intoblished by Elsevier B.V. All rights reserved.
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SGT without the stop code was cloned to pcDNA3.1-myc-His-A vec-
tor via EcoRI and BamHI restriction sites. Various deletion mutants
were generated through PCR using cDNA of SGT as the template
and subcloned into pcDNA3.0 vector via the same sites. The sense oli-
gonucleotide (5 0-GATCC ACGTGGAGGCCGTGGCTTA TTCAA-
GAGA TAAGCCACGGCCTCCACGTGC TTTTTTGGAAA-30)
and antisense oligonucleotide (50-AGCTTTTCCAAAAAA GCACGT-
GGAGGCCGTGGCTTA TCTCTTGAA TAAGCCACGGCCTC-
CACGT G-30) were annealed and then cloned to piSilencer 2.1 vector.
Clones were sequenced to identiﬁed the siRNA template insert.
2.3. Cell culture, transfection, FCM analysis and cell count
The 7721 Cells were cultured in RPMI-1640 medium supplemented
with 10% (v/v) fetal calf serum, 100 units/ml of penicillin and 50 lg/ml
of streptomycin at 37 C under 5% CO2 in humidiﬁed air. African
green monkey kidney COS-1 cells (Institute of Cell Biology, Academic
Sinica) were cultured in Dulbeccos modiﬁed Eagles medium supple-
mented with 10% (v/v) fetal calf serum, 100 units/ml penicillin, and
50 lg/ml streptomycin. Cells were transfected with diﬀerent plasmids
using lipofectAMINE according to the manufacturers recommenda-
tion. Clone selection was conducted by culturing with G418 (400 lg/
ml). Stable transfectants with high expression of the target genes were
identiﬁed by Northern-blot analysis.
For growth curves, 3 · 103 cells were plated. Subsequently cells were
counted at 72 h intervals in triplicate using a hemocytometer [14].
After ﬁxation in cold ethanol for 12 h, cells were washed again with
phosphate-buﬀered saline (PBS) and then stained with a solution con-
taining 50 lg/ml propidium iodide (PI), 250 lg/ml RNase, and 0.1%
Triton X-100 and analyzed by quantitative ﬂow cell cytometry with
standard optics of FACScan ﬂow cytometer (BD PharMingen FAC-
Star) employing the Cell Quest program.
2.4. Induction and measurement of apoptosis
Hoechst 33258 staining of nuclei. Morphological changes in the nu-
clear chromatin in cells undergoing apoptosis were detected by staining
with the DNA binding ﬂuorochrome Hoechst 33258. Cells were grown
on glass coverslips and treated with either STS or CHX. Cells were
washed twice with PBS and ﬁxed by incubation in 4% paraformalde-
hyde for 30 min. Following washes with PBS, cells were incubated in
25 lg/ml Hoechst 33258 solutions for 30 min in the dark chamber.
Coverslips were then washed with PBS and analyzed by ﬂuorescence
microscopy.
DNA fragmentation assay. After treating with CHX for the indicated
time, cells were harvested and washed with PBS followed by centrifu-
gation at 12000 · g in a microcentrifuge for 30 s at 4 C. Cells were
lysed in solution (0.5% SDS, 10 mM EDTA, 0.5 mg/ml proteinase K,
and 50 mM Tris–HCl, pH 8.0). DNA was extracted with a standard
phenol–chloroform method and precipitated with cold ethanol. The
pellets were dried and resuspended in 100 ml of 20 mM Tris–HCl,
pH 8.0. After digesting RNA with RNase (0.1 mg/ml) at 37 C for
1 h, samples were electrophoresed through a 1.2% agarose gel DNA
was visualized with UV light.
Apoptosis analysis by annexin-V PI staining. This analysis was per-
formed as described before [15]. To use annexin-V to detect cell surface
PS, the cells were washed twice in PBS and then resuspended in bind-
ing buﬀer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, and
2.5 mM CaCl2). 195 ll of cell suspension containing 10
5 cells was ta-
ken, and 5 ll of annexin-V-FITC was added, mixed, and incubated
for 10 min in the dark. After that, the cells were washed twice in
PBS and resuspended in 190 ll of binding buﬀer. 10 ll of 20 lg/ml
PI was added and then analyzed by ﬂuorescence-activated cell sorting.
Apoptotic cells could be stained with annexin-V but not PI.
2.5. Northern blot, Western blot and isolation of mitochondria and
cytosolic fraction
Total RNA was isolated using Trizol reagent according to the man-
ufacturers instructions. RNA concentrations were calculated by mea-
suring UV light absorbance at 260 nm. Each RNA sample (40 lg) was
denatured and subjected to electrophoresis in 1% agarose gel contain-
ing 2.2 M formaldehyde. RNA was transferred to Hybond-N+ nylon
membrane (Amersham, UK) and cross-linked by UV irradiation using
a GS Gene Linker UV chamber (Bio-Rad, CA, USA). Northern-blot
analysis was performed as described before [16], using the[a-32P]dATP-labeled SGT fragments as probes. The widely used
cDNA of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
adopted as an intrinsic standard during Northern-blot analysis.
Total protein (40 lg) was extracted and resolved to immunoblot
analysis as described before [15]. To isolate the mitochondrial and
cytosolic fraction, cells were washed with PBS, resuspended in CFS
buﬀer (10 mM HEPES–NaOH (pH 7.2), 0.22 M mannitol, 68 mM su-
crose, 2 mM NaCl, 2.5 mM KH2PO4, 0.5 mM EGTA, 2 mM MgCl2,
5 mM sodium pyruvate, 0.1 mM phenylmethylsulfonyl ﬂuoride, and
1 mM dithiothreitol) and homogenized by aspiration through a 22-
gauge needle. The homogenate was centrifuged at 700 · g for 5 min,
and the resulting supernatant was centrifuged for 10 min at
10000 · g to obtain a pellet enriched in mitochondria and a postmito-
chondrial supernatant as the cytosolic fraction.2.6. RT-PCR analysis
Total RNA was extracted from 7721 cells using Trizol reagent.
Then, 0.5 lg of RNA from each sample was reverse-transcribed into
cDNA according to the manufacturers manuals. The cDNA was
ampliﬁed by PCR with the following primers: SGT (950 bp) 5 0-GAT-
GAATTCATGGACAACAAGAAGCGCC-30 (sense primer) and 5 0-
GATCTCGAGTCACTCCTGCTGGTCGTC-3 0 (antisense primer).
The expression levels of actin (5 0-aaccgtgaaaagatgacccag-3 0 sense pri-
mer, 5 0-ctcctgcttgctgatccacat-30 antisense primer) analyzed by RT-
PCR assays were used as a internal control. The expression level of
SGT during apoptosis was quantitated by densitometric analysis.3. Results
3.1. Ectopic expression of SGT promotes apoptosis in 7721 cell
It is known that three TPR motif proteins (including CHIP,
TPR2, and Strap) can modulate cell death in diﬀerent mecha-
nism [17–19]. Therefore, it raised the possibility that SGT may
be also involved in apoptosis. To test this idea, pcDNA3-SGT
expression vector and pcDNA3 empty vector were transfected
into 7721 cells. After selection of the G418-resisted colonies,
the expression of SGT mRNA was highly expressed in
pcDNA3-SGT transfected cells (7721/SGT) compared with
that in the parent and pcDNA3-transfected cells (Mock, Fig.
1A). Next, we investigated the role of SGT in apoptosis. After
exposure to CHX for the indicated time, the genomic DNA
were extracted and then resolved in 1.2% agarose gel,
Fig. 1B shows that SGT induced fragmentation of chromo-
somes (lanes 4 and 6), whereas the fragment of chromosomes
did not appear in Mock cells (lanes 3 and 5). Furthermore,
we quantitated the apoptotic cells by annexin-V and PI stain-
ing. After the 7721 cells were incubated with CHX for the indi-
cated time, the percentage of apoptotic cells was not be altered
(Fig. 1C, panels a and b). However, overexpression of SGT
sensitized 7721 cells to apoptosis, the percentage of apoptotic
cells was increased from 4% to 19% (Fig. 1C, panels c and
d). Thus, we concluded that SGT is a pro-apoptotic protein,
but not an anti-apoptotic factor like other TPR family proteins
which are associated with apoptosis.
3.2. Endogenous SGT is associated with apoptosis in 7721 cells
Above results indicated that exogenous SGT displayed the
pro-apoptotic activity. Thus, we asked whether endogenous
SGT is also involved in apoptosis. We therefore examined
whether the mRNA level of SGT was altered during apoptosis.
Cells were incubated with either CHX or STS for the indicated
time, following a time-course analysis the change of SGT
mRNA during apoptosis. The mRNA of SGT was increased
when cells treated with STS for 2 h (Fig. 2A, lane 2), while
Fig. 1. Ecotopic expression of SGT promotes apoptosis in 7721 cells.
(A) Identiﬁcation of stable 7721 cell lines expressing pcDNA3.0-SGT
(7721/SGT). Total RNA (30 lg) from mock cells (lane Mock) and
7721/SGT cells (lane SGT) were extracted and subjected to Northern-
blot analysis. (Note: the exogenous SGT mRNA is 941 bp, the
endogenous SGT mRNA is 2.4 kb). GAPDH was used as an internal
control. (B) Stably transformed 7721 cell lines expressing pcDNA3.0
(Mock, lanes 1, 3, and 5) or 7721/SGT (lanes 2, 4, and 6) were treated
with 10 lg/ml CHX for the indicated time. DNA were isolated,
resolved on an agarose gel, stained with ethidium bromide, and
visualized for DNA fragmentation by UV transillumination. (C) Mock
cells (panels a and b) and 7721/SGT cells (panel c and d) were treated
with (panels b and d) or without (panels a and c) 10 lg/ml CHX for
24 h, the cells were stained with annexin-V and PI as described in
Section 2.
H. Wang et al. / FEBS Letters 579 (2005) 1279–1284 1281the increase of SGT expression was apparent only after 12 h
exposure of cells to CHX (Fig. 2B, lane 2). Furthermore, the
upregulation of SGT mRNA is prior to the onset of apoptosis
(data not shown). Next, we used RNA interference to suppress
the expression of SGT to test our above hypothesis. We ﬁrst
veriﬁed the eﬃciency of the designed siRNA in COS-1 cells
(Fig. 2C, left panel), then we used the siRNA to knockdown
the endogenous in 7721 cells (Fig. 2C, right panel). It is showed
that transfection with the siRNA SGT decreased the apoptosis
by about 40%, compared with cells transfected with mock vec-
tor. From the above results, we can conclude that the endoge-
nous SGT is also involved in apoptosis in 7721 cells.
3.3. TPR domain is required for the SGT pro-apoptotic activity
Previous studies showed that TPR domain is critical for the
anti-apoptotic function of several TPR family proteins [17,18].
To investigate whether the three TPR motifs are required for
the pro-apoptotic function of SGT, we constructed a series
of deletion mutants of SGT as indicated (Fig. 3B). These mu-
tants were transfected into 7721 cells, respectively, to test its
apoptosis-inducing ability. It is to be noted that only the do-main containing the three TPR motifs (Fig. 3A, F2, F4 mu-
tant) displayed its capacity of pro-apoptosis. On the
contrary, overexpression of the mutant containing the other
domain could not induce apoptosis. These results imply that
three TPR motifs are crucial for the apoptosis-inducing ability
of SGT.
3.4. Ectopic expression of SGT does not aﬀect cellular
proliferation or cell cycle progression
We considered the possibility that ectopic expression of SGT
might exert its pro-apoptotic activity by aﬀecting the rate of
cellular proliferation. We therefore compared the growth
kinetics of 7721 cells and 7721/SGT cells. Fig. 4A showed that
the growth curves of 7721 cells were similar with those of 7721/
SGT cells, which indicated that SGT expression does not aﬀect
the cellular proliferation. To gain further insight into whether
ectopic expression of SGT has a subtle eﬀect on cell growth, we
made use of DNA ﬂow cytometry to compare the cell cycle of
7721/SGT cells with that of mock cells, the data (Fig. 4B)
showed that the distribution of 7721/SGT in G1, S, G2/M
phase were not diﬀerent from that of mock cells. Taken to-
gether, we concluded that SGT exerts its pro-apoptotic func-
tion without aﬀecting cellular proliferation and cell cycle.
3.5. Enhancement of PARP cleavage and release of cytochrome c
from mitochondria by the overexpression of SGT
Caspase activity and cytochrome c release are known to be
the major events in apoptotic tumor cells. Therefore, we asked
whether caspase activation and cytochrome c release are mod-
ulated by the overexpression of SGT. Fig. 5A showed that the
number of apoptotic cell was obviously reduced when 7721/
SGT cells were incubated with pancaspase inhibitor (V-
ZAD-FMK) just one hour before treatment with CHX. The
above observation indicated that the activation of caspases
may be involved in apoptosis induced by SGT expression.
For it has been well documented that the activation of Caspase
3 is responsible for the cleavage of PARP which is required for
cell death in various cell lines [20], we therefore examined the
cleavage of PARP during apoptosis to assess the activation
of Caspase 3. As shown in Fig. 5B, the 89 kDa fragment of
PARP in 7721/SGT cells which was cleaved by Caspase 3
was more apparent than that of mock cells. Furthermore, after
exposure to STS for 3 h, cytochrome c was released from mito-
chondria to cytosol in 7721/SGT cells but not in mock cells
(Fig. 5C). Therefore, we proposed that the activation of casp-
ases and cytochrome c release occur in 7721/SGT cells during
apoptosis.4. Discussion
The tetratricopeptide, which was originally identiﬁed in
1990, comprises a degenerate 34-amino acid repeated motif
that is widespread in a variety of diﬀerent organisms ranging
from bacteria to humans [3,21,22]. To date, the known three-
dimensional structure data have shown that a TPR motif con-
tains two anti-parallel a-helices, therefore tandem arrays of
TPR motifs generate a right-handed helical structure with an
amphipathic channel that might accommodate the comple-
mentary region of the target protein [3,22]. Owing to the spe-
ciﬁc structure, TPR mediates protein–protein interactions
and the assembly of macromolecular protein complexes.
Fig. 2. The endogenous SGT is associated with apoptosis. After exposure of 7721 cells to STS (panel A) or CHX (panel B) for the indicated time,
total RNA was isolated from 7721 cells, 0.5 lg RNA was used to perform RT-PCR analysis to assess the level of SGT mRNA, actin was used as a
internal control. Results quantitated by densitometric analysis are representative of three repeated experiments. (C) Knockdown of SGT by RNA
interference. Left panel: the pcDNA3.1/myc-His() A-SGT and pEGFP were cotransfected to COS-1 cells with mock pSilencer vector (lane Mock)
or siRNA SGT (lane siRNA), then the expression of SGT was detected by Western blot with anti-myc antibody. Western blot for GFP was used as a
control for equal protein and transfection eﬃciency. Right panel: the mock pSilencer vector (Mock) or siRNA SGT (siRNA) were, respectively,
transfected to 7721 cells, the level of SGT mRNA was analyzed by RT-PCR. (D) Suppression of endogenous SGT decreased apoptosis of 7721 cells.
The mock pSilencer vector (left panel: M; right panel: Mock) or siRNA SGT (left panel: S; right panel: siRNA) were, respectively, transfected to 7721
cells, 48 h after transfection, cells were treated with STS for 6 h, then cells were ﬁxed and stained with Hoechst 33258. The apoptotic cells were
counted by ﬂuorescence microscopy. Representative results (means ± S.D.) from one out of three independent experiments are presented (right
panel).
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in a variety of biological processes, such as cell cycle control,
transcriptional repression, protein folding, protein transport
and neurogenesis [3,21,22]. For instance, anaphase-promoting
complex (APC), which contains TPR motif protein including
Cdc16, Cdc23, and Cdc27, functions as a mitotic E3 ligase that
target proteins for degradation at the onset of anaphase
[23,24]. Ssn6, which contains 10 copies of TPR motifs, forms
a complex with other proteins, and then the complex is re-
cruited by diﬀerent transcription factors to repress gene tran-
scription [25].
Nevertheless, the speciﬁc functions of the individual TPR
protein are still to be elucidated. As a member of TPR family
proteins, SGT has been found to interact with several proteins
including Myostatin, NS1, Vpu, etc. However, little is know
about the biological signiﬁcance of these interactions. In the
present study, we showed that SGT had a role in apoptosis.The apoptotic activity of SGT was conﬁrmed through DNA
fragment, Hoechst staining and annexin-V PI staining. In fact,
several proteins have been reported to be involved in apopto-
sis. Moreover, our results showed that the endogenous SGT is
also associated with apoptosis (Fig. 3). The ﬁrst TPR motif
protein that was reported to be associated with apoptosis is
Strap, which is present in the p300/CBP transcription factor
complex. Strap enhances the stability of p53 and in turn regu-
lates apoptosis by modulating MDM2 activity [18]. Next,
TPR2, which carries both a J domain and TPR motif, interacts
with Rad9 that controls apoptosis by interacting with Bcl-2
protein, therefore it is proposed to be involved in apoptosis
[19]. Finally, CHIP, which was originally identiﬁed as a protein
that interacted with Hsc70 and carries both a TPR motif and
U-box, cooperates with Hsp70 and Parkin and inhibits cell
death induced by unfolded Pael-R in some types of Parkin-
sonss disease through the ubiquitin proteasome protein degra-
Fig. 3. TPR domain is important for the apoptotic activity of SGT.
(A) 7721 cells were transfected with a series of deletion mutants shown
in (B), 24 h after transfection, cells were ﬁxed and stained with Hoechst
33258. Then, the apoptotic cells were counted by ﬂuorescence
microscopy. Representative results (means ± S.D.) from one out of
four independent experiments are presented. (B) Schematic diagram of
SGT and its mutants, SGT contains three TPR motifs as indicated.
Fig. 4. SGT does not aﬀect cellular proliferation and cell cycle. (A)
Cellular proliferation analysis. 3 · 103 cells of 7721 cell (circle) or 7721/
SGT (triangle) were seeded and cell number were counted by && at the
indicated time. (B) Cell cycle analysis. The distribution of each phase
of asynchronous cells including 7721 and 7721/SGT cells were
quantitated by ﬂow cytometry. The percentage of G1, S, G2/M are
listed as indicated.
Fig. 5. Caspase 3 activity and cytochrome c release are induced by
SGT overexpression. (A) Mock cells (panels a and c) and 7721/SGT
cells (panels b and d) were incubated with (panels b and d) or without
(panels a and c) the pancaspase inhibitor Z-VAD-FMK (50 lM) for
one hour followed by treating with 10 lg/ml CHX for 24 h. After
staining by Hoechst 33258, the apoptotic cells were counted by
ﬂuorescence microscopy. (B) Control 7721 cells (con), 7721 stably
expressing pcDNA3.0 (Mock) and 7721 stably expressing pcDNA3.0-
SGT (7721/SGT) were incubated with 0.2 lM STS for 3 h, 40 lg total
protein were extracted and subjected to immunoblot analysis for
PARP. (C) Three cell lines described above were, respectively,
incubated with 0.2 lM STS for 3 h, cytosolic and mitochondrial
fractions were isolated and subjected to immunoblot analysis for
cytochrome c and Hsp60.
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trimerization and transcriptional activation of HSF1 and con-
fers protection against apoptosis [26]. Above all, the TPR do-
main of all protein described above are important for their
anti-apoptotic activity. As expected, we found that the TPR
domain of SGT is also responsible for its function in apopto-
sis. However, the TPR domain of SGT is not anti-apoptotic
like other TPR family protein but is pro-apoptotic.
Despite that our observations indicated that SGT exerts a
role in apoptosis, it is unlikely that SGT is a direct eﬀector
in apoptosis according to our known knowledge that the
known TPR motif proteins are not the eﬀector [17–19,26].
On the contrary, the regulator role of SGT in apoptosis de-
pends on its ability to interact with other proteins. Therefore
the identiﬁcation of the apoptosis-associated interacting part-
ner for SGT should help deﬁne its molecular mechanism in
apoptosis. At the molecular level, Hsp70 and Hsc70 may be
the best candidate binding partners which are involved in
apoptosis. Hsp70 or Hsc70 protects cells against multiple
apoptotic stimuli including DNA damage, UV irradiation, ser-
um withdrawal and a variety of chemotherapeutic agents [27].
Much of existing evidence seem to indicate that Hsp70 protects
apoptosis within the mitochondria-mediated pathway and spe-
ciﬁcally (but not necessarily) downstream of mitochondria at
the level of the apoptosome. For example, Saleh et al. [28]
showed that the interaction between Hsp70 and Apaf-1 inhib-
ited the oligomerization of Apaf-1 and subsequent recruitment
and activation of procaspase-9. But another report showed
that Hsp70 maintain the oligomer in a conformation incom-
patible with procaspase-9 recruitment by preventing exposure
of the Apaf-1 CARD domain [29]. On the other hand, it is
showed that Hsp70 prevents cleavage and activation of Bid,
independent of its chaperone activity [30]. Moreover, recent
1284 H. Wang et al. / FEBS Letters 579 (2005) 1279–1284data also indicated that Hsp70 cooperates with Hsp40 to pre-
vent the translocation of BAX from cyotosol to mitochondria
and subsequent inhibit nitric-oxide-induced apoptosis [31].
Based on the above observations, it is reasonable to speculate
that SGT can negatively modulate the chaperone activity of
Hsc70 or Hsp70 [8,9] and in turn make 7721 cells more suscep-
tible to apoptosis because the chaperone activity of either
Hsc70 or Hsp70 is necessary to its capacity of anti-apoptosis
[32,33], but it is to be noted that the chaperone activity of
Hsc70 can also be positively regulated by SGT [11]. The con-
trary results imply that SGT may also protect apoptosis, which
is consistent with the observation reported by Winnefeld et al.
[12] in NBE cells. A rational explanation for above controver-
sial observations is that SGT exerts its anti-apoptotic function
or pro-apoptotic function through two diﬀerent pathways,
respectively, in diﬀerent cell lines. That is to say, it is possible
that SGT has dual functions in apoptosis. However, in 7721
cells it displays the pro-apoptotic activity.
In brief, our study demonstrated that SGT is involved in
apoptosis in 7721 cells, and like other TPR motif protein,
the TPR domain is important for its function in apoptosis,
the caspase activation and cytochrome c release, the pivotal
events in apoptosis, are also observed in the SGT overexpress-
ing cells. However, further work need to be performed to elu-
cidate how SGT sensitizes cells to apoptosis.
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